AFMD Affimed N.V.
Healthcare$0.18+0.00%ClosedMarket Cap: $3.0M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
0.00
EV/EBITDA
0.19
DCF Value
$-7.06
FCF Yield
-8096075.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-1289.0%
Net Margin
-1280.2%
ROE
-100.5%
ROA
-109.0%
ROIC
-137.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $155.0K | 100.0% | $-14.3M | $-15.1M | $— | — |
| Q2 null | $154.0K | 100.0% | $-15.6M | $-15.5M | $— | — |
| Q1 null | $155.0K | 100.0% | $-19.5M | $-19.2M | $— | — |
| Q4 null | $413.0K | 100.0% | $-20.8M | $-20.2M | $— | — |
| FY null | $8.3M | 100.0% | $-106.7M | $-105.9M | $— | — |
| Q3 null | $2.0M | 100.0% | $-24.9M | $-24.4M | $— | — |
| Q2 null | $1.4M | 100.0% | $-29.4M | $-29.4M | $— | — |
| Q1 null | $4.5M | 100.0% | $-31.5M | $-32.0M | $— | — |
| Q4 null | $11.2M | 100.0% | $-30.1M | $-36.7M | $— | — |
| FY null | $41.4M | 100.0% | $-88.1M | $-86.0M | $— | — |
| Q3 2022 | $14.9M | 100.0% | $-19.2M | $-13.8M | $-0.92 | — |
| Q2 2022 | $7.3M | 100.0% | $-21.7M | $-17.2M | $-1.16 | — |